Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Hyperion Therapeutics 

2000 Sierra Point Parkway
Suite 400
San Francisco  California  94005  U.S.A.
Phone: 1-650-745-7802 or 1-888-897-4276 Fax: 650-871-7029


 Company News
Hyperion Therapeutics (HPTX) Announces Data Published In Genetics In Medicine Showing Blood Ammonia And Glutamine As Predictors Of Hyperammonemic Crises In Patients With Urea Cycle Disorders 1/12/2015 7:36:16 AM
Hyperion Therapeutics (HPTX) Added To Nasdaq Biotechnology Index (NBI) 12/19/2014 7:43:06 AM
Hyperion Therapeutics (HPTX) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/5/2014 11:52:34 AM
Hyperion Therapeutics (HPTX) To Present At The Jefferies and Co. 2014 Global London Healthcare Conference 11/14/2014 10:15:17 AM
Hyperion Therapeutics (HPTX) To Report Third Quarter 2014 Financial Results After Market On November 6, 2014 10/31/2014 7:42:22 AM
Hyperion Therapeutics (HPTX), Clal Biotechnology Industries Resolve Dispute Over $570 Million Biotech Problem 10/7/2014 7:16:31 AM
Hyperion Therapeutics (HPTX) To Present At The Leerink Rare Disease Roundtable 9/25/2014 7:39:03 AM
Hyperion Therapeutics (HPTX) To Host Analyst Day September 30, 2014 9/24/2014 7:19:21 AM
Bay Area's Hyperion Therapeutics (HPTX) Tanks As Employee Misconduct Leads To Drug Trial Halt 9/8/2014 7:04:34 AM
Hyperion Therapeutics Appoints Theodore Schroeder To Board Of Directors 8/12/2014 3:25:05 PM